Patient motivation for non-persistence with medication impacts self-reported compliance
Main Article Content
Abstract
1.1 Introduction
In 2004 we initiated an inception cohort of patients with recent-onset rheumatoid arthritis (RA). From 2008 onward, compliance (C) was assessed at fixed intervals, using a questionnaire (CQ) that additionally investigated 15 predefined motivations for non-persistence with therapy (P), and a visual analogue scale (C-VAS, 0-100mm). Objectives were to examine the correlation between the CQ and the C-VAS and to investigate if the selection of patient-independent motivations for non-P predicted better self-reported C.
1.2 Materials and methods
Up to January 2016, the cohort comprised 180 patients with variable follow-up. Each pre-specified motivation for non-P was classified as patient-dependent or patient-independent by 50 patients randomly selected (≥70% agreement). Descriptive statistics and multiple regression analysis were used. Written informed consent was obtained.
1.3 Results
Length of follow-up from 160 patients for which data were completed and analyzed was 6.7±3.4 years; all the patients scored 1516 pairs of CQ and C-VAS. C-VAS significantly correlated with the CQ, r=0.468, p=0.001. Optimal C-VAS cut-off value to predict CQ-compliance was ≤7.5 mm.
During follow-up, there were 670 CQ scored as with non-P among whom, 654 had at least one motivation for non-P selected; of them, 549 CQ (70.2%) corresponded to non-P patients who selected only patient-independent motivations. The selection of exclusively independent motivations for non-P predicted C-VAS and CQ scores. Also, the selection of exclusively independent motivations for non-P predicted compliance either per VAS (OR: 15.6, 95%CI: 5.4-45.3, p≤0.001) or per CQ (OR: 2.25, 95%CI: 1.062-4.664, p=0.034).
1.4 Conclusions
Patient motivation for non-persistence with medication impacts self-reported C.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional non-adherers and intentional non-adherers: application of the necessity-concerns framework. J Psychosomat Res 2008; 64:41-46.
Contreras-Yáñez I, Cabiedes J†, Villa AR, Rull-Gabayet M, Pascual-Ramos V. Persistence on therapy is a major determinant of patient-, physician- and laboratory- reported outcomes in recent-onset rheumatoid arthritis patients. Clin Exp Rheumatol 2010;28:748-51.
Contreras-Yáñez I, Ponce de León S, Cabiedes J†, Rull-Gabayet M, Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease modifying antirheumatic drugs. Am J Med Sc 2010; 340(4):282-90.
Grigor C, Capell H, Stirling A. Effect of treatment strategy of tight control for Rheumatoid Arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004; 364 (9430):263-9.
Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis : a randomized controlled trial. Ann Rheum Dis 2001 ; 60 :869-75.
Horne R, Weinman J. Patient´s beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999 ; 47 :555-567.
Jing J, Grant ES, Vernon MSO, Shu CL. Factors affecting therapeutic compliance: A review from the patient´s perspective, Ther Clin Risk Manag 2008; 4(1):269-86.
Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE Jr, et al. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response. Am J Manag Care 2002;8:231-40.
Lati C, Guthrie LC, Ward MM. Comparison of the construct validity and sensitivity to change of the visual analogue scale and a modified rating scale as measures of patient global assessment in rheumatoid arthritis. J rheumatol 2010 ; 37(4) :717-22.
Lorish CD, Richards B, Brown S. Missed medication doses in rheumatic arthritis patients: intentional and unintentional reasons. Arthritis Care Res 1989; 2:3-9.
McCormack HM, Horne DJ, Sheater S. Clinical applications of visual analogue scales: a critical review. Psychol Med 1988; 18(4):1007-19.
Mody GM, Cardiel MH. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol 2008;22:621-41.
Morrison DP. The Crichton visual analogue scale for the assessment of behavior in teh elderly. Acta Psy Scan 1983 ; 68 :408-13.
Neame R, Hammond A. Beliefs about medications : a questionnaire survey of people with rheumatoid arthitis. Rheumatol 2005 ; 44 :762-67.
Pascual-Ramos V, Contreras-Yáñez I. Motivations for inadequate persistence with disease modifying antirheumatic drugs. The patient´s perspective. BMC Musculoskeletal Disorders 2013;14:336.
Pascual-Ramos V, Contreras-Yáñez I, Villa AR, Cabiedes J†, Rull-Gabayet M. Medication persistence over two years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and disability. Arthritis Res Ther 2009;11(1):R26.
Pasma A, van´t Spijker A, Hazes JMW, Busschbach, Luime JJ. Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients : A systematic review. Sem Arthritis Rheum 2013 ; 43 :18-28.
Rampling DJ, Williams RA. Evaluation of group processes using visual analogue scales. Australina and New Zealand J Psych 1977 ; 11 :189-91.
Rosenstock IM, Strecher VJ, Becher MH. Social learning theory and the Health Belief Model. Health Educ Quart 1988 ; 152 :175-83.
Sanderson T, Kirwan J. Patient-reported outcomes of arthritis: time to focus on personal life impact measures? Editorial Arthritis Rheum 2009;61:1-3.
Scheiman-Elazary, Lewei D, Shourt C, Agrawal H, Ellashof D, Cameron-Hay M, et al. The rate of adherence to antiarthritis medications and associated factors among patients with rheumatoid arthritis: A systematic literature review and Metaanalysis. J
Rheumatol 2016; 43(3):512-23.
Scott J, Huskinsson EC. Graphic representation of pain. Pain 1976 ; 2 :175-84.
Van der Bemt BJF, Zwikker HE, VAN DEN Ende C. Medication Adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Exp Rev Clin Immunol 2012; 8(4):337-51.
Van Dulmen S, Sluijs E, VAN Dijk L, De Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment : a review of reviews. BMC Health Services Research 2007; 7 :55.
Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
World Health Organization. Adherence to long-term therapies: evidence for action. 2016. [Internet. Accessed June 10, 2016.]. Available from : www.who.int/chp/knowledge/publication/adherence_report/en